rxstatShortages › Nystatin

Nystatin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Nystatin products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 8
In shortage since
Jun 3, 2026
Reports on file
58
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · since Jun 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP-NYSTATIN ORAL SUSPENSION USP
100000UNIT · SUSPENSION · JAMP PHARMA CORPORATION
DIN 02433443 · ended Aug 18, 2025 · Demand increase for the drug.
Resolved
JAMP-NYSTATIN ORAL SUSPENSION USP
100000UNIT · SUSPENSION · JAMP PHARMA CORPORATION
DIN 02433443 · ended Jul 14, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
Resolved
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · ended Oct 30, 2024 · Disruption of the manufacture of the drug.
Resolved
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · ended Oct 29, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Discontinued
NYADERM
25000UNIT · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716901
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Jun 18, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Jan 10, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Dec 13, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 58 reports. All reports are on file with Health Canada.

What's happening

Nystatin is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Nystatin is classified under “INTESTINALANTIINFECTIVES” (ATC A07AA).

Recent changes

Common questions

When will Nystatin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Nystatin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (intestinalantiinfectives)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.